Search Results 1071-1080 of 19873 for Receptor

  1. Pembrolizumab Plus Epacadostat Alone or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-02/ECHO-306) - Mayo Clinic

    Histologically or cytologically confirmed diagnosis of stage IV NSCLC without epidermal growth factor receptor (EGFR)-sensitizing mutation, ROS1 and/or ...

  2. Reactive hypoglycemia: What causes it? - Mayo Clinic

    Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin- ...

  3. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    ... Receptor T Cell Therapy. Transplant Cell Ther. 2024 Apr; 30 (4):455.e1-455.e7 Epub 2024 Feb 10. View PubMed; Walker J, McCarty T, McGwin G, Ordaya EE ...

  4. Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ vaccine

    ... receptor," says Dr. Amy Degnim, a surgeon with the Mayo Clinic Cancer Center. "HER2 is a protein that in some cases is on the outside of cancer cells and ...

  5. A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients With Advanced or Metastatic Renal Cell Carcinoma - Mayo Clinic

    ... receptor (VEGFR) (e.g., sunitinib, pazopanib, sorafenib, tivozanib, cabozantinib). One prior immunotherapy (interleukin-2 or interferon-alpha or immune ...

  6. Publications - Michelle P. Lin, M.D., M.P.H. - Mayo Clinic

    Interleukin-1 receptor role in the viability of corneal myofibroblasts. Exp Eye Res. 2012 Mar; 96 (1):65-9 Epub 2012 Jan 10. View PubMed; Allan EJ, Flowers ME ...

  7. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

    ... receptor radiotherapy (PRRT) and PRRT must be completed at least 8 weeks prior to registration; Radiological evidence for progressive disease (measureable or ...

  8. Ovarian Cancer Clinical Trials - Mayo Clinic Research

    ... receptor alpha will have persistent T cell and antibody responses to folate receptor alpha and will have broad evidence of systemic immune activation. A ...

  9. Nicotine Dependence Center: 25 years of research - Mayo Clinic News Network

    ... receptors in the brain," Dr. Croghan says. Using ... "Varenicline targets the nicotine receptor, partially stimulating and partially blocking," Dr.

  10. Tambi Jarmi, M.D. - Mayo Clinic Faculty Profiles

    Focus areas · Using stem cells for organ rehabilitation. Dr. · Applying chimeric antigen receptor (CAR) T-cell therapy to desensitize patients before transplant.